Company news
CollPlant Biotechnologies Ltd. news in 2024
CollPlant Biotechnologies Ltd.'s news releases, calls and decks from 2024, newest first.
CollPlant Biotechnologies reports 2024 third quarter financial results and provides corporate update
November 26, 2024
CollPlant Biotechnologies announces date for 2024 third quarter financial results and conference call information
November 11, 2024
CollPlant Biotechnologies reports 2024 second quarter financial results and provides corporate update
August 19, 2024
CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants
August 18, 2024
CollPlant Biotechnologies announces date for 2024 second quarter financial statements and conference call information
August 5, 2024
CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report
July 28, 2024
CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data
June 5, 2024
CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update
May 28, 2024
CollPlant Biotechnologies announces date for 2024 first quarter financial results and conference call information
May 15, 2024
CollPlant Biotechnologies reports 2023 full year financial results and provides corporate update
April 3, 2024
CollPlant Biotechnologies announces date for 2023 full year financial results and conference call information
March 25, 2024
CollPlant Issues Letter to Shareholders
February 14, 2024
CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California
January 7, 2024
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
January 1, 2024
Calls in 2024
- Collplant Biotechnologies (NASDAQ:CLGN) Q3 2024 Earnings Call
Nov 27, 2024
Transcript - Collplant Biotechnologies (NASDAQ:CLGN) Q2 2024 Earnings Call
Aug 20, 2024
Transcript - Collplant Biotechnologies (NASDAQ:CLGN) Q1 2024 Earnings Call
May 29, 2024
Transcript - Collplant Biotechnologies (NASDAQ:CLGN) Q4 2023 Earnings Call
Apr 4, 2024
Transcript